F
F. D. Verbraak
Researcher at University of Amsterdam
Publications - 16
Citations - 378
F. D. Verbraak is an academic researcher from University of Amsterdam. The author has contributed to research in topics: Optical coherence tomography & Slit lamp. The author has an hindex of 8, co-authored 16 publications receiving 343 citations.
Papers
More filters
Journal ArticleDOI
Influence of cataract on optical coherence tomography image quality and retinal thickness
TL;DR: In this article, a three-level expert grading scale was used to evaluate the discriminative abilities of signal-to-noise ratio (SNR) and signal strength and macular thickness.
Journal ArticleDOI
Evaluation of central serous retinopathy with en face optical coherence tomography
M. E. J. van Velthoven,F. D. Verbraak,Patricia Garcia,Reinier O. Schlingemann,Richard B Rosen,M. D. de Smet +5 more
TL;DR: The optical coherence tomography (OCT) ophthalmoscope provides complementary morphological information on patients with CSR and lends further support to the concept that CSR is a diffuse rather than localised RPE anomaly.
Journal ArticleDOI
Comparing the effectiveness of bevacizumab to ranibizumab in patients with exudative age-related macular degeneration. The BRAMD study
Ann-Sofie M E Schauwvlieghe,Greet Dijkman,Johanna M. M. Hooymans,F. D. Verbraak,Carel B. Hoyng,Marcel G. W. Dijkgraaf,Tunde Peto,Johannes R. Vingerling,Reinier O. Schlingemann +8 more
TL;DR: The response to bevacizumab was more varied with higher percentages of both gainers and losers and more frequently observed retinal fluid on SD-OCT at 12 months when compared to the ranibizumabs group.
Journal ArticleDOI
Added value of OCT in evaluating the presence of leakage in patients with age-related macular degeneration treated with PDT.
TL;DR: There was considerable disagreement between leakage as judged by OCT and by FA, and OCT could be of help in the decision regarding PDT retreatment.
Journal ArticleDOI
Single spot PDT in patients with circumscribed choroidal haemangioma and near normal visual acuity
TL;DR: It is demonstrated that single spot PDT might be an effective treatment for CCH with a visual acuity ≥20/30, without serious side-effects during a follow-up of at least 18 months.